A Rapid Synthesis of 2-Aryl-5-substituted-2,3-dihydrobenzofurans
摘要:
An effective strategy has been developed for the rapid and efficient one-pot synthesis of 2-aryl-5-substituted-2,3-dihydrobenzofurans from readily available o-nitrotoluenes and aromatic aldehydes. This strategy allows access to a structurally diverse array of products for further manipulation.
Tetrahydropteridines useful as inhibitors of protein kinases
申请人:Charrier Jean-Damien
公开号:US20090062292A1
公开(公告)日:2009-03-05
The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
[EN] THERAPEUTICALLY ACTIVE THIAZOLO-PYRIMIDINE DERIVATIVES<br/>[FR] DÉRIVÉS THIAZOLO-PYRIMIDINE THÉRAPEUTIQUEMENT ACTIFS
申请人:UCB PHARMA SA
公开号:WO2013068458A1
公开(公告)日:2013-05-16
A series of thiazolo[5,4-d]pyrimidine derivatives of formula (I) or an N-oxide thereof, or a pharmaceutically acceptable salt or solvate thereof: (I) Q represents a group of formula (Qa), (Qb), (Qc), (Qd) or (Qe) are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases; and organ and cell transplant rejection.
Therapeutically Active Thiazolo-Pyrimidine Derivatives
申请人:UCB Pharma S.A.
公开号:US20140315885A1
公开(公告)日:2014-10-23
A series of thiazolo[5,4-d]pyrimidine derivatives of formula (I) or an N-oxide thereof, or a pharmaceutically acceptable salt or solvate thereof: (I) Q represents a group of formula (Qa), (Qb), (Qc), (Qd) or (Qe) are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases; and organ and cell transplant rejection.
Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases
申请人:Vertex Pharmaceuticals Incorporated
公开号:US08067417B2
公开(公告)日:2011-11-29
The present invention relates to compounds useful as inhibitors of protein kinase, represented by Structural Formula (I):
wherein the variables in Structural Formula (I) are as described herein. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
[1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases
申请人:Charrier Jean-Damien
公开号:US08524902B2
公开(公告)日:2013-09-03
The present invention relates to compounds useful as inhibitors of protein kinase, represented by Structural Formula (I):
wherein the variables in Structural Formula (I) are as described herein. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.